LYSOGENE

Lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders . Their mission is to radically improve the health of patients suffering from incurable life threatening conditions. They do this by developing AAV vectors that have demonstrated their effectiveness in safely delivering genetic material to the central nervous system.

LYSOGENE

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Medical Pharmaceutical

Founded:

2009-01-01

Address:

Neuilly-sur-seine, Ile-de-France, France

Country:

France

Website Url:

http://www.lysogene.com

Total Employee:

11+

Status:

Active

Contact:

+33 1 56 88 52 86

Total Funding:

30.26 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins

Similar Organizations

amr-centre-logo

AMR Centre

AMR Centre is a joint private-public initiative to support/accelerate the development of new antibiotics and diagnostics.

aprea-logo

Aprea

Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.

aristea-therapeutics-logo

Aristea Therapeutics

Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.

calypso-biotech-logo

Calypso Biotech

Calypso Biotech's vision is to give new hope to patients suffering from severe gastro-intestinal diseases.

clene-nanomedicine-logo

Clene Nanomedicine

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

ethris-logo

ETHRIS

ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.

finvector-logo

FinVector

FinVector is a world leader in the research and development of Viral-Based Gene Therapy products.

iag-image-analysis-group-logo

IAG, Image Analysis Group

IAG, imaging expert company helps to accelerate novel drug development by using the right analytical tools and modern trial infrastructure.

nmd-pharma-logo

NMD Pharma

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

pharnext-logo

Pharnext

Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.

phasebio-pharmaceuticals-logo

PhaseBio Pharmaceuticals

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

polyneuron-logo

POLYNEURON

Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.

versameb-logo

Versameb

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

Current Employees Featured

olivier-danos_image

Olivier Danos
Olivier Danos Senior Vice President Molecular Medicine @ LYSOGENE
Senior Vice President Molecular Medicine

ralph-laufer_image

Ralph Laufer
Ralph Laufer Chief Scientific Officer @ LYSOGENE
Chief Scientific Officer
2018-05-01

not_available_image

Stéphane Durant des Aulnois
Stéphane Durant des Aulnois Chief Financial Officer @ LYSOGENE
Chief Financial Officer

karen-pignet-aiach_image

Karen Pignet-Aiach
Karen Pignet-Aiach Founder, Chief Executive Officer @ LYSOGENE
Founder, Chief Executive Officer
2009-01-01

marie-deneux_image

Marie Deneux
Marie Deneux Head of Regulatory affairs @ LYSOGENE
Head of Regulatory affairs
2019-04-01

sophie-olivier_image

Sophie Olivier
Sophie Olivier Chief Medical Officer @ LYSOGENE
Chief Medical Officer
2017-05-01

samantha-parker_image

Samantha Parker
Samantha Parker Chief Patient Access Officer @ LYSOGENE
Chief Patient Access Officer
2014-08-01

Founder

karen-pignet-aiach_image

Karen Pignet-Aiach

Stock Details

Company's stock symbol is EPA:LYS

Investors List

european-investment-bank_image

Official Site Inspections

http://www.lysogene.com Semrush global rank: 3.78 M Semrush visits lastest month: 3.56 K

Host Informations
Whois Informations

Loading ...